Eric Vallieres, MD, FRCS(C)
Dr Eric Vallières is the Medical Director Division of Thoracic Surgery at the Swedish Cancer Institute in Seattle. He received his MD from L’Université Laval in Canada. Following an internship in Québec City, he trained in General Surgery at the University of Toronto where he also completed a General Thoracic Surgery Residency. Dr. Vallières was Vice-Chairman of the Lung Committee with SWOG from 1998 to 2008. He sat on the Staging and Membership Committees of the International Association for the Study of Lung Cancer and was also a member of its Education Committee. His main interests are the combined modality approaches to thoracic malignancies, adjuvant therapy after lung cancer surgery and clinical trials in thoracic oncology. He was the surgical PI of the S9900 Intergroup phase III trial which evaluated the role of pre-operative chemotherapy in lung cancer. Since 1997, he has led the combined modality efforts to the treatment of mesothelioma in Seattle and in the Pacific Northwest. Dr. Vallières has editorial responsibilities at the Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, Journal of Thoracic Oncology, Clinical Lung Cancer, Chest, Lung Cancer, Annals of Surgical Oncology, Journal of Clinical Oncology and New England Journal of Medicine. His bibliography includes 156 published articles and 49 book chapters.
Financial relationships
-
Attribution:SelfType of financial relationship:OtherIneligible company:AstraZenecaTopic:Consultant/ SpeakerDate added:08/26/2022Date updated:07/19/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:OncocyteTopic:SpeakerDate added:08/26/2022Date updated:07/19/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:Bristol Myers SquibbTopic:ConsultantDate added:08/26/2022Date updated:07/19/2024